Published in BMC Med Res Methodol on May 03, 2012
Quality of reporting in systematic reviews of adverse events: systematic review. BMJ (2014) 1.81
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ (2017) 1.40
Drug induced diseases (DID): Need for more awareness & research. Indian J Med Res (2015) 1.06
Bayesian Estimation and Testing in Random Effects Meta-analysis of Rare Binary Adverse Events. Stat Biopharm Res (2015) 0.75
Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study. BMJ Open (2016) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med (2007) 33.21
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA (1998) 32.05
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry (1999) 8.04
Complications of central venous catheters: internal jugular versus subclavian access--a systematic review. Crit Care Med (2002) 5.69
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med (2004) 5.67
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA (1998) 5.37
Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA (2001) 5.09
Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain (2000) 4.93
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA (2002) 4.92
Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA (2002) 4.72
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med (2007) 4.56
Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med (1999) 4.41
Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc (1999) 4.35
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med (2010) 3.79
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation (1994) 3.65
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry (2004) 3.59
Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol (2001) 3.44
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ (2007) 3.40
Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet (2000) 3.36
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med (2004) 3.12
Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 3.08
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ (2000) 3.02
Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res (2001) 2.96
How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med (2005) 2.95
Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology (2003) 2.93
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev (2010) 2.91
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med (2003) 2.90
Hysterectomy and urinary incontinence: a systematic review. Lancet (2000) 2.89
Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc (1999) 2.76
Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death. Ann Intern Med (2007) 2.76
Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ (2003) 2.74
Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med (1994) 2.74
Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc (2009) 2.74
Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet (2003) 2.71
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol (2001) 2.69
Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ (1998) 2.61
Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol (1999) 2.59
A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol (2002) 2.54
Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ (1998) 2.50
Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr (2003) 2.45
A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol (2002) 2.45
Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg (1998) 2.44
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med (1999) 2.42
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. Arch Intern Med (2004) 2.40
Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol (1997) 2.37
Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM (2001) 2.34
Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol (2001) 2.33
Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA (2001) 2.32
Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol (1995) 2.30
Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis. Lancet (2000) 2.17
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc (2003) 2.00
Meta-analysis of the safety of home birth. Birth (1997) 1.99
The association between vasectomy and prostate cancer: a systematic review of the literature. Fertil Steril (1998) 1.98
A systematic overview of the incidence of posterior capsule opacification. Ophthalmology (1998) 1.98
A comparison of statistical methods for combining event rates from clinical trials. Stat Med (1989) 1.95
Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev (2003) 1.91
Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception (2003) 1.86
Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus Med (1996) 1.82
Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology (2000) 1.78
Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med (1997) 1.77
Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med (2000) 1.73
Meta-analysis for 2 x 2 tables: a Bayesian approach. Stat Med (1992) 1.71
Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE. Health Info Libr J (2006) 1.70
IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception (1995) 1.70
Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol (2001) 1.63
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant (2004) 1.62
Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA (2000) 1.61
The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis. Crit Care Med (2000) 1.60
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab (1996) 1.58
Safety of vaginal birth after cesarean: a systematic review. Obstet Gynecol (2004) 1.58
Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke (2003) 1.58
Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure. Am J Cardiol (1997) 1.53
A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. Int J Geriatr Psychiatry (2004) 1.52
Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart (2003) 1.51
Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy. JAMA (2001) 1.50
Routine perioperative pulmonary artery catheterization has no effect on rate of complications in vascular surgery: a meta-analysis. Am Surg (2001) 1.49
A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14,237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone. Pharmacoepidemiol Drug Saf (2008) 1.48
Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review. Epilepsia (2002) 1.48
A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol (1994) 1.47
Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer (2001) 1.42
Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol (2007) 1.41
An application of meta-analysis techniques in the evaluation of adverse experiences with antihypertensive agents. Pharmacoepidemiol Drug Saf (1999) 1.39
A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol (1998) 1.38
Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol (1997) 1.35
Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol (R Coll Radiol) (1997) 1.34
Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol (1997) 1.31
Early postnatal discharge from hospital for healthy mothers and term infants. Cochrane Database Syst Rev (2002) 1.30
Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med (2006) 12.44
Comparison of two methods to detect publication bias in meta-analysis. JAMA (2006) 7.34
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol (2006) 5.13
Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med (2005) 4.45
Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med (2005) 3.73
Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial. JAMA (2002) 3.42
Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making (2012) 3.36
How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med (2005) 2.95
Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol (2008) 2.93
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis (2010) 2.67
Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke (2006) 2.64
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ (2008) 2.63
Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol (2002) 2.49
Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making (2013) 2.43
Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med (2009) 2.43
Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making (2013) 2.39
A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. J Environ Sci Health B (2006) 2.23
Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol (2007) 2.13
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics (2006) 2.10
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value Health (2011) 2.05
Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol (2009) 2.01
Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence. Lancet (2002) 1.91
Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med (2009) 1.90
Finding qualitative research: an evaluation of search strategies. BMC Med Res Methodol (2004) 1.89
Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med (2010) 1.89
The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol (2005) 1.88
Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study). Eur Urol (2012) 1.88
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (2011) 1.86
Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med (2007) 1.83
Quality of reporting in systematic reviews of adverse events: systematic review. BMJ (2014) 1.81
An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics (2007) 1.74
Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach. Stat Med (2005) 1.72
The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) (2010) 1.69
Clinical and cost-effectiveness of a new nurse-led continence service: a randomised controlled trial. Br J Gen Pract (2005) 1.68
Adverse drug reactions in children--a systematic review. PLoS One (2012) 1.65
Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res Methodol (2009) 1.51
A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res (2004) 1.47
A multicomponent decision tool for prioritising the updating of systematic reviews. BMJ (2013) 1.42
Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Econ (2011) 1.41
The use of systematic reviews when designing studies. Clin Trials (2005) 1.39
Are we sure about the evidence for zinc in prophylaxis of the common cold? Expert Rev Respir Med (2012) 1.38
Evidence-based sample size calculations based upon updated meta-analysis. Stat Med (2007) 1.35
An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization. Am J Epidemiol (2004) 1.26
Evidence synthesis for decision making 5: the baseline natural history model. Med Decis Making (2013) 1.25
Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Econ (2004) 1.24
Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ (2004) 1.18
Scoping review and approach to appraisal of interventions intended to involve patients in patient safety. J Health Serv Res Policy (2010) 1.18
Home safety education and provision of safety equipment for injury prevention. Cochrane Database Syst Rev (2012) 1.17
How should we use information about HWE in the meta-analyses of genetic association studies? Int J Epidemiol (2007) 1.17
Evidence synthesis for decision making 7: a reviewer's checklist. Med Decis Making (2013) 1.16
A generalized weighting regression-derived meta-analysis estimator robust to small-study effects and heterogeneity. Stat Med (2012) 1.14
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future. BMC Neurol (2009) 1.12
Effectiveness of interventions designed to promote patient involvement to enhance safety: a systematic review. Qual Saf Health Care (2010) 1.11
Evidence synthesis for decision making 1: introduction. Med Decis Making (2013) 1.09
Mixed treatment comparisons using aggregate and individual participant level data. Stat Med (2012) 1.08
Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One (2012) 1.08
Comments on 'trying to be precise about vagueness' by Stephen Senn, Statistics in Medicine 2007; 26:1417-1430. Stat Med (2008) 1.07
Bayesian implementation of a genetic model-free approach to the meta-analysis of genetic association studies. Stat Med (2005) 1.07
Recreational drug use: a major risk factor for gastroschisis? Am J Epidemiol (2007) 1.07
The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques. Crit Care Med (2007) 1.07
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study. BMC Med Res Methodol (2011) 1.06
So many filters, so little time: the development of a search filter appraisal checklist. J Med Libr Assoc (2008) 1.05
Planning future studies based on the conditional power of a meta-analysis. Stat Med (2012) 1.05
Multivariate meta-analysis of mixed outcomes: a Bayesian approach. Stat Med (2013) 1.05
Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis. Health Econ (2007) 1.04
When is a further clinical trial justified? BMJ (2012) 1.03
When to wait for more evidence? Real options analysis in proton therapy. Oncologist (2011) 1.02
The effectiveness and cost-effectiveness of respite for caregivers of frail older people. J Am Geriatr Soc (2007) 1.01
Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present. J Clin Epidemiol (2004) 1.01
Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS Med (2011) 0.99
Surgical versus nonsurgical treatment of acute minimally displaced and undisplaced scaphoid waist fractures: pairwise and network meta-analyses of randomized controlled trials. J Hand Surg Am (2011) 0.98
Identifying quality improvement intervention publications--a comparison of electronic search strategies. Implement Sci (2011) 0.98
Network meta-analysis to evaluate the effectiveness of interventions to increase the uptake of smoke alarms. Epidemiol Rev (2011) 0.98
The impact of under and over-recording of cancer on death certificates in a competing risks analysis: a simulation study. Cancer Epidemiol (2012) 0.98
Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med (2012) 0.97
Flexible parametric joint modelling of longitudinal and survival data. Stat Med (2012) 0.97